|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/137 | |||
| A61K 31/485 | |||
| A61K 47/18 | |||
| A61K 47/26 | |||
| A61P 25/30 | |||
| A61P 25/36 |
| (11) | Number of the document | 2379111 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09831343.0 |
| Date of filing the European patent application | 2009-12-14 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2009/001778 |
| Date | 2009-12-14 |
| (87) | Number | WO 2010/066034 |
| Date | 2010-06-17 |
| (30) | Number | Date | Country code |
| 122117 P | 2008-12-12 | US |
| (72) |
VINSON, Robert, CA
GOSSELIN, Patrick, CA
BETANCOURT, Aimesther, Ojito, CA
|
| (73) |
Paladin Labs Inc.,
6111 Royalmount Avenue, Suite 102, Montreal, QC H4P 2T4,
CA
|
| (54) | NARCOTIC DRUG FORMULATIONS WITH DECREASED ABUSE POTENTIAL |
| NARCOTIC DRUG FORMULATIONS WITH DECREASED ABUSE POTENTIAL |